Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-1896
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands ; volume:17 ; number:6 ; day:23 ; month:8 ; year:2019 ; pages:857-873 ; date:12.2019
Applied health economics and health policy ; 17, Heft 6 (23.8.2019), 857-873, 12.2019

Creator
Michels, Renée Else
Fransesco, Maria de
Mahajan, Koshu
Hengstman, Gerald J. D.
Schiffers, Krijn M. H.
Budhia, Sangeeta
Harty, Gerard
Krol, Marieke
Contributor
SpringerLink (Online service)

DOI
10.1007/s40258-019-00500-8
URN
urn:nbn:de:101:1-2020042920134968356037
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Michels, Renée Else
  • Fransesco, Maria de
  • Mahajan, Koshu
  • Hengstman, Gerald J. D.
  • Schiffers, Krijn M. H.
  • Budhia, Sangeeta
  • Harty, Gerard
  • Krol, Marieke
  • SpringerLink (Online service)

Other Objects (12)

Relapsing/remitting type 1 diabetes

Relapsing/remitting type 1 diabetes

Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review

Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review

Endocarditis following ocrelizumab in relapsing-remitting MS

Endocarditis following ocrelizumab in relapsing-remitting MS

Postural Control in Relapsing-Remitting Multiple Sclerosis

Postural Control in Relapsing-Remitting Multiple Sclerosis

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Relapsing–remitting painful ophthalmoplegia due to orbital myositis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Abnormal multisensory integration in relapsing–remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis

Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis

Related objects